Global burden of hematologic malignancies and evolution patterns over the past 30 years

Hematologic malignancies are among the most common cancers, and understanding their incidence and death is crucial for targeting prevention, clinical practice improvement, and research resources appropriately. Here, we investigated detailed information on hematological malignancies for the period 1990-2019 from the Global Burden of Disease study. The age-standardized incidence rate (ASIR), the age-standardized death rate (ASDR), and the corresponding estimated annual percentage changes (EAPC) were calculated to assess temporal trends in 204 countries and territories over the past 30 years. Globally, incident cases of hematologic malignancies have been increasing since 1990, reaching 1343.85 thousand in 2019,…

• NN
  National Natural Science Foundation of China

  Award: 81770179
• WU
  Wuhan University

  Award: ZNLH201902
• ZH
  Zhongnan Hospital of Wuhan University

  Awards: ZNLH201902, PDJH202217